Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01733420
Other study ID # 2011/538
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date October 4, 2011
Est. completion date February 2016

Study information

Verified date November 2021
Source University Ghent
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A clinical trial to evaluate and compare three different products used for endodontic treatment (taking the infected nerve out of the teeth) of primary teeth. Null Hypothesis: The new biological products (WMTA and Biodentine) behave as good as the former iodoform product.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date February 2016
Est. primary completion date November 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 2 Years to 9 Years
Eligibility Inclusion Criteria: - Patients (Children with carious deciduous molars indicated for pulpotomy) belonging to the category of ASA I according to the 'American Society of Anaesthesiologists'. - Patients without any known medical history of systemic complications contradicting pulp treatment. - Patients are indicated for treatment under general anaesthesia due to polycaries / fear / anxiety / very young age. - Written consent is obtained from the parent/guardian after explaining the full details of the treatment procedure and its possible outcomes.

Study Design


Related Conditions & MeSH terms

  • Extensive Decay in Primary Molars

Intervention

Drug:
Biodentine pulpotomy

White MTA pulpotomy

Tempophore pulpotomy


Locations

Country Name City State
Belgium Ghent University Hospital Ghent

Sponsors (1)

Lead Sponsor Collaborator
University Ghent

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical successes after pulpotomy. clinical evaluation and radiography of the tooth is performed. Clinical criteria: abscence of post-operative pain, absence of pain on percussion and palpation, absence of abscess or swelling, absence of sinus tract or fistula and absence of pathologic tooth mobility. at baseline visit
Primary Clinical success after pulpotomy. clinical evaluation and radiography of the tooth is performed. Clinical criteria: abscence of post-operative pain, absence of pain on percussion and palpation, absence of abscess or swelling, absence of sinus tract or fistula and absence of pathologic tooth mobility. 3 months after pulpotomy.
Primary Clinical successes after pulpotomy. Clinical evaluation and radiography of the tooth is performed. Clinical criteria: abscence of post-operative pain, absence of pain on percussion and palpation, absence of abscess or swelling, absence of sinus tract or fistula and absence of pathologic tooth mobility. 6 months after pulpotomy.
Primary Clinical successes after pulpotomy. Clinical evaluation and radiography of the tooth is performed. Clinical criteria: abscence of post-operative pain, absence of pain on percussion and palpation, absence of abscess or swelling, absence of sinus tract or fistula and absence of pathologic tooth mobility. 12 months after pulpotomy.
Primary Radiographic successes after pulpotomy. Radiographic criteria: presence of normal periodontal ligament space, absence of internal or external root resorption, absence of canal calcification, absence of periradicular radiolucency and no loss or break of lamina dura. at baseline visit
Primary Radiographic successes after pulpotomy. Radiographic criteria: presence of normal periodontal ligament space, absence of internal or external root resorption, absence of canal calcification, absence of periradicular radiolucency and no loss or break of lamina dura. 6 months after pulpotomy.
Primary Radiographic successes after pulpotomy. Radiographic criteria: presence of normal periodontal ligament space, absence of internal or external root resorption, absence of canal calcification, absence of periradicular radiolucency and no loss or break of lamina dura. 12 months after pulpotomy.
See also
  Status Clinical Trial Phase
Completed NCT03135626 - Comparison of The Success Rates of Four Different Pulpotomy Techniques Phase 3